dibutylnitrosamine has been researched along with valsartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leclerc, J | 1 |
| Faustino, PJ; Mohammad, A; Selaya, SD; Shakleya, D; Zhang, J | 1 |
2 other study(ies) available for dibutylnitrosamine and valsartan
| Article | Year |
|---|---|
Recall of N-Nitrosodimethylamine-Contaminated Pseudogeneric Valsartan: Best Generics Finally No Better Than Others?
Topics: Angiotensin II Type 1 Receptor Blockers; Drug Contamination; Drug Recalls; Drugs, Generic; Humans; Nitrosamines; Valsartan | 2018 |
Rapid Quantitation of Four Nitrosamine Impurities in Angiotensin Receptor Blocker Drug Substances.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Humans; Losartan; Nitrosamines; Tandem Mass Spectrometry; Valsartan | 2023 |